Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Helicobacter pylori eradication therapy
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pylera 140mg/125mg/125mg capsules
0103050A0BDAAAC
|
Pylera | Helicobacter pylori eradication therapy | Gastro-Intestinal System | 75 |
|
Generic HeliClear
0103050A0AAAAAA
|
Helicobacter pylori eradication therapy | Helicobacter pylori eradication therapy | Gastro-Intestinal System | No data available |
|
Generic HeliMet
0103050A0AAABAB
|
Helicobacter pylori eradication therapy | Helicobacter pylori eradication therapy | Gastro-Intestinal System | No data available |
|
Generic Pylera 140mg/125mg/125mg capsules
0103050A0AAACAC
|
Helicobacter pylori eradication therapy | Helicobacter pylori eradication therapy | Gastro-Intestinal System | No data available |
|
HeliClear
0103050A0BBAAAA
|
HeliClear | Helicobacter pylori eradication therapy | Gastro-Intestinal System | No data available |
|
HeliMet
0103050A0BCAAAB
|
HeliMet | Helicobacter pylori eradication therapy | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.